Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.

<h4>Background</h4>In a previous report, we hypothesized that responses to placebo were high in child and adolescent depression because of specific psychopathological factors associated with youth major depression. The purpose of this study was to compare the placebo response rates in ph...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: David Cohen, Emmanuelle Deniau, Alejandro Maturana, Marie-Laure Tanguy, Nicolas Bodeau, Réal Labelle, Jean-Jacques Breton, Jean-Marc Guile
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2008
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0279ccf519424712bd2d503f1de68a2b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0279ccf519424712bd2d503f1de68a2b
record_format dspace
spelling oai:doaj.org-article:0279ccf519424712bd2d503f1de68a2b2021-11-25T06:11:40ZAre child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.1932-620310.1371/journal.pone.0002632https://doaj.org/article/0279ccf519424712bd2d503f1de68a2b2008-07-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18612460/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>In a previous report, we hypothesized that responses to placebo were high in child and adolescent depression because of specific psychopathological factors associated with youth major depression. The purpose of this study was to compare the placebo response rates in pharmacological trials for major depressive disorder (MDD), obsessive compulsive disorder (OCD) and other anxiety disorders (AD-non-OCD).<h4>Methodology and principal findings</h4>We reviewed the literature relevant to the use of psychotropic medication in children and adolescents with internalized disorders, restricting our review to double-blind studies including a placebo arm. Placebo response rates were pooled and compared according to diagnosis (MDD vs. OCD vs. AD-non-OCD), age (adolescent vs. child), and date of publication. From 1972 to 2007, we found 23 trials that evaluated the efficacy of psychotropic medication (mainly non-tricyclic antidepressants) involving youth with MDD, 7 pertaining to youth with OCD, and 10 pertaining to youth with other anxiety disorders (N = 2533 patients in placebo arms). As hypothesized, the placebo response rate was significantly higher in studies on MDD, than in those examining OCD and AD-non-OCD (49.6% [range: 17-90%] vs. 31% [range: 4-41%] vs. 39.6% [range: 9-53], respectively, ANOVA F = 7.1, p = 0.002). Children showed a higher stable placebo response within all three diagnoses than adolescents, though this difference was not significant. Finally, no significant effects were found with respect to the year of publication.<h4>Conclusion</h4>MDD in children and adolescents appears to be more responsive to placebo than other internalized conditions, which highlights differential psychopathology.David CohenEmmanuelle DeniauAlejandro MaturanaMarie-Laure TanguyNicolas BodeauRéal LabelleJean-Jacques BretonJean-Marc GuilePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 3, Iss 7, p e2632 (2008)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
David Cohen
Emmanuelle Deniau
Alejandro Maturana
Marie-Laure Tanguy
Nicolas Bodeau
Réal Labelle
Jean-Jacques Breton
Jean-Marc Guile
Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.
description <h4>Background</h4>In a previous report, we hypothesized that responses to placebo were high in child and adolescent depression because of specific psychopathological factors associated with youth major depression. The purpose of this study was to compare the placebo response rates in pharmacological trials for major depressive disorder (MDD), obsessive compulsive disorder (OCD) and other anxiety disorders (AD-non-OCD).<h4>Methodology and principal findings</h4>We reviewed the literature relevant to the use of psychotropic medication in children and adolescents with internalized disorders, restricting our review to double-blind studies including a placebo arm. Placebo response rates were pooled and compared according to diagnosis (MDD vs. OCD vs. AD-non-OCD), age (adolescent vs. child), and date of publication. From 1972 to 2007, we found 23 trials that evaluated the efficacy of psychotropic medication (mainly non-tricyclic antidepressants) involving youth with MDD, 7 pertaining to youth with OCD, and 10 pertaining to youth with other anxiety disorders (N = 2533 patients in placebo arms). As hypothesized, the placebo response rate was significantly higher in studies on MDD, than in those examining OCD and AD-non-OCD (49.6% [range: 17-90%] vs. 31% [range: 4-41%] vs. 39.6% [range: 9-53], respectively, ANOVA F = 7.1, p = 0.002). Children showed a higher stable placebo response within all three diagnoses than adolescents, though this difference was not significant. Finally, no significant effects were found with respect to the year of publication.<h4>Conclusion</h4>MDD in children and adolescents appears to be more responsive to placebo than other internalized conditions, which highlights differential psychopathology.
format article
author David Cohen
Emmanuelle Deniau
Alejandro Maturana
Marie-Laure Tanguy
Nicolas Bodeau
Réal Labelle
Jean-Jacques Breton
Jean-Marc Guile
author_facet David Cohen
Emmanuelle Deniau
Alejandro Maturana
Marie-Laure Tanguy
Nicolas Bodeau
Réal Labelle
Jean-Jacques Breton
Jean-Marc Guile
author_sort David Cohen
title Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.
title_short Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.
title_full Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.
title_fullStr Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.
title_full_unstemmed Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.
title_sort are child and adolescent responses to placebo higher in major depression than in anxiety disorders? a systematic review of placebo-controlled trials.
publisher Public Library of Science (PLoS)
publishDate 2008
url https://doaj.org/article/0279ccf519424712bd2d503f1de68a2b
work_keys_str_mv AT davidcohen arechildandadolescentresponsestoplacebohigherinmajordepressionthaninanxietydisordersasystematicreviewofplacebocontrolledtrials
AT emmanuelledeniau arechildandadolescentresponsestoplacebohigherinmajordepressionthaninanxietydisordersasystematicreviewofplacebocontrolledtrials
AT alejandromaturana arechildandadolescentresponsestoplacebohigherinmajordepressionthaninanxietydisordersasystematicreviewofplacebocontrolledtrials
AT marielauretanguy arechildandadolescentresponsestoplacebohigherinmajordepressionthaninanxietydisordersasystematicreviewofplacebocontrolledtrials
AT nicolasbodeau arechildandadolescentresponsestoplacebohigherinmajordepressionthaninanxietydisordersasystematicreviewofplacebocontrolledtrials
AT reallabelle arechildandadolescentresponsestoplacebohigherinmajordepressionthaninanxietydisordersasystematicreviewofplacebocontrolledtrials
AT jeanjacquesbreton arechildandadolescentresponsestoplacebohigherinmajordepressionthaninanxietydisordersasystematicreviewofplacebocontrolledtrials
AT jeanmarcguile arechildandadolescentresponsestoplacebohigherinmajordepressionthaninanxietydisordersasystematicreviewofplacebocontrolledtrials
_version_ 1718414022493077504